The Covid vaccination distribution has officially started in the country. Covishield vaccine is being developed and distributed by Oxford University in association with AstraZeneca. During this situation, it is natural to have doubts and queries about the Covishield vaccine. A group of doctors are here to clear those queries.
Covishield is a vaccine developed by the Serum Institute of India in collaboration with the Jenner Institute at Oxford University and the AstraZeneca Company.
The vaccine is a vector that modifies a type of adenovirus that infects chimpanzees. The genetic sequence required to produce the thorn-like spike protein in the mantle of the coronavirus SARS coV2 - 19 is integrated into the above vector virus.
This allows the person receiving the vaccine to produce the spike protein, and then produces Antibodies against it and acquires immunity.
As of now, those above eighteen years of age are permitted to take the vaccination.
Studies on the safety and efficacy of the vaccine in children under the age of 18, pregnant and lactating mothers are currently unavailable.
These matters should be disclosed to health workers prior to vaccination.
The vaccine is given in two doses of 0.5 ml each. The injection should be taken in the muscle on the left. The interval between two doses can range from 4 to 12 weeks, but the Indian government and vaccine manufacturers have defined an interval of four weeks.
The efficiency of this vaccine is about 70 percent. However, it is said that the vaccine can be 100% effective against getting severe. It should be taken four weeks after the second dose to achieve complete immunity.
It is a relatively safe vaccine with no serious side effects.
Very common side effects (more than 10% of people)
(Written by: Dr. Sunil PK, Dr. Purushothaman KK, Dr. Kiran Narayanan, Dr. Jinesh PS)